
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
Yulei Li, Peipei Liu, Tianjiao Hao, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Yulei Li, Peipei Liu, Tianjiao Hao, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Showing 9 citing articles:
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
Yen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access
Yen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access
Unravelling Insights into the Evolution and Management of SARS-CoV-2
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 385-409
Open Access | Times Cited: 2
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 385-409
Open Access | Times Cited: 2
Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variants
Yaling An, Xuemei Zhou, Lifeng Tao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Yaling An, Xuemei Zhou, Lifeng Tao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
A novel “prime and pull” strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge
Zhannan Wang, Yingkai He, Wenfeng Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Zhannan Wang, Yingkai He, Wenfeng Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants
Tianjiao Hao, Yulei Li, Peipei Liu, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012508-e1012508
Open Access
Tianjiao Hao, Yulei Li, Peipei Liu, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012508-e1012508
Open Access
SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice
Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126463-126463
Open Access
Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126463-126463
Open Access
Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters
Ekaterina Stepanova, Victoria Matyushenko, Daria A Mezhenskaia, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1300-1300
Open Access
Ekaterina Stepanova, Victoria Matyushenko, Daria A Mezhenskaia, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1300-1300
Open Access
A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV
Nan Gao, Tianhan Yang, Lanlan Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Nan Gao, Tianhan Yang, Lanlan Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access